Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Titre croissant(e)) Affiner la rechercheArticle
A. Beddok ; B. Porte ; P. Cottu ; A. Fourquet ; Y. Kirova |Plusieurs études cliniques ont montré que les inhibiteurs de kinase dépendante des cyclines 4/6 (CDK4/6i) permettaient d’allonger la survie des patientes atteintes d’un cancer du sein surexprimant les récepteurs hormonaux et ne surexprimant pas [...]Article
S. Allali ; V. Servois ; A. Beddok ; A. Fourquet ; Y. Kirova |Purpose The coronavirus disease 2019 (covid-19) caused by the severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) is at the origin of a global pandemic. This pandemic has prompted the current health system to reorganize and rethink the [...]Article
P. Loap ; F. Goudjil ; R. Dendale ; Y. Kirova |/Purpose : Protontherapy for mediastinal Hodgkin lymphoma reduces cardiac, lung and breast exposure, which may limit radiation-induced adverse events. While this technique is already widely implemented in the United-States, clinical experience i[...]Article
The coronavirus disease 2019 (COVID-19) pandemic has caused a global upheaval in our health care system. Our hospital facilities have been subjected to a major influx of patients and the prevention of cross-contamination has been a key issue in [...]Article
K. Quintin ; P. Loap ; A. Fourquet ; Y. Kirova |Purpose: Helical tomotherapy (HT) is a rotational intensity-modulated radiation therapy (IMRT) technique that allows target conformal irradiation and efficient organs at risk (OAR) sparing in the case of complex target volumes and specific anato[...]Article
F. Courtinat ; P. Cottu ; J.-G. Féron ; N. Jehanno ; A. Fourquet ; Y. Kirova ; A. Beddok |Breast cancer is a frequent and sometimes fatal disease. The risk of locoregional recurrence has considerably decreased since the introduction of adjuvant treatments (radiotherapy, chemotherapy, hormone therapy). Nevertheless, some patients pres[...]Article
P. Loap ; A. Barcellini ; L. de Marzi ; E. Orlandi ; Y. Kirova |Hadrontherapy is a form of radiation therapy (RT) that relies on heavy particles, such as proton, heavy ions, or neutrons, to enhance anti-tumoral efficacy based on their specific dosimetric and radio-biological properties. Neutrons are characte[...]Article
M. Michalet ; C. Dejean ; U. Schick ; C. Durdux ; A. Fourquet ; Y. Kirova |We present the updated recommendations of the French society for radiation oncology on radiotherapy and pregnancy. The occurrence of cancer during pregnancy is a rare event (approximately 1 in 1000 pregnancies). The risks for the embryo or the f[...]Article
I. Chaffai ; K. Cao ; M. Kissel ; R. El Ayachy ; A. Aboudaram ; A. Fourquet ; Y. Kirova |Objectif de l’étude La radiothérapie hypofractionnée modérée est devenue une pratique de routine pour une population sélectionnée de patientes traitées pour un cancer du sein de stade précoce. En avril 2020 est publiée l’étude Fast Forward qui [...]Article
S. Allali ; F. Chasset ; Y. Kirova ; C. Saint-Martin ; P. Moguelet ; A. Fourquet ; A. Beddok |Data on the incidence and severity of radiation-induced toxicity in patients with systemic and/or cutaneous lupus erythematosus (SLE/CLE) are very limited. After reporting the case of a patient who experienced major toxicity and CLE flare in the[...]
